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Abstract
Objective: To examine the association between cardiovascular risk and childhood
overweight and obesity using the BMI cut-offs recommended by the WHO.
Design: Children were classified as normal weight, overweight and obese
according to the WHO BMI-for-age reference. Blood pressure, lipids, glucose,
insulin, homeostasis model assessment–insulin resistance (HOMA-IR) and uric
acid levels were compared across BMI groups. ANOVA and tests of linearity were
used to assess overall mean differences across groups. Crude and adjusted odds
ratios were calculated for adverse plasma levels of biochemical variables.
Setting: Paediatric care centres.
Subjects: Children (n 149) aged 8–18 years.
Results: About 37%, 22% and 41% of children were classified respectively as
normal weight, overweight and obese. There were significant linear mean dif-
ferences between BMI groups in systolic blood pressure, HDL-cholesterol, TAG,
insulin, HOMA-IR and uric acid. Obese children were 10?6 times more likely than
normal-weight children to have hypertension; OR for other associations were
60?2 (high insulin), 39?5 (HOMA-IR), 27?9 (TAG), 16?0 (HDL-cholesterol),
4?3 (LDL-cholesterol) and 3?6 (uric acid). Overweight children were more likely
than normal-weight children to have hypertension (OR5 3?5), high insulin
(OR5 28?2), high HOMA-IR (OR5 23?3) and high TAG (OR5 16?1). Nearly 92%
and 57% of the obese and overweight children, respectively, had one or more
risk factor.
Conclusions: Obesity and overweight defined using the WHO BMI-for-age cut-
offs identified children with higher metabolic and vascular risk. These results
emphasize the importance of prevention of overweight and obesity in childhood
to reduce cardiovascular risk.
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The worldwide prevalence of childhood overweight and
obesity has increased in recent decades(1,2). As a result, CVD
risk factors such as lipid disorders, insulin resistance and
diabetes are increasingly being diagnosed in children(3).
Anthropometric references play an important role in
identifying children who are overweight or obese, or at risk
of becoming so. In 2007, the WHO released growth refer-
ence data for school-aged children and adolescents aged
5–19 years (hereafter referred to as ‘the WHO reference’)(4).
The new WHO reference is based on a reconstruction of
the US National Center for Health Statistics 1977 reference
curves using the original sample (a non-obese sample
with expected heights), supplemented with data from the
pre-school WHO Child Growth Standards(4). The resulting
WHO curves, recommended for both clinical and epide-
miological use, are widely used by country programmes
and researchers around the world to define childhood
overweight and obesity(5,6).
The WHO reference BMI-for-age curves at 19 years
closely coincide with adult overweight (BMI5 25?0kg/m2)
at 11 SD and adult obesity (BMI5 30?0 kg/m2) at 12 SD.
These standard deviation classifications have been exten-
ded to 5 years to define the cut-off thresholds for over-
weight and obesity in children aged 5–19 years(5). The
objective of the present study was to assess the associa-
tion between several CVD risk factors and BMI status
using the WHO cut-offs to define overweight and obesity.
Assessing these associations will help determine if the
WHO cut-offs that are being broadly used are clinically
and biologically meaningful and, thus, useful in identi-
fying individual children and populations in need of
CVD-prevention strategies.
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Methods
Study design and participants
A prospective study was conducted among 149 school-
children and adolescents aged 8–18 years (ninety-nine boys
and fifty girls) attending primary paediatric care centres in
Valencia, Spain. Ninety-four participants were randomly
selected from a sample of children referred from the pri-
mary centres to the Pediatric Gastroenterology and Nutrition
Unit of the Hospital Clı´nico Universitario because of over-
weight and obesity for follow-up. Additionally, fifty-five
normal-weight children from the same primary care centres,
referred for a functional heart murmur study, were also
randomly selected. Children with dysmorphic syndromes
and/or endocrinological disorders were excluded. Informed
consent from the parent/guardian was obtained in all cases.
The study protocol was approved by the Hospital Clı´nico
Universitario of Valencia Committee on Ethical Practice.
Clinical assessment
Each child’s weight and height were collected using a
standardized technique(7) and BMI-for-age Z-scores cal-
culated based on the WHO reference(4). Children with
BMI Z-score between $22 and #11 were classified as
normal weight; those with Z-score between .11 and
#12 (equivalent to BMI5 25?0 kg/m2 at 19 years) were
considered overweight; and those with Z-score .12
(equivalent to BMI5 30?0 kg/m2 at 19 years) as obese(4,5).
Blood pressure was measured in all children by the same
researcher using the same device (DinamapR oscillometric
method). High values were checked with the auscultatory
method and mercury sphygmomanometer. The sleeve size
was adjusted to fit arm diameter, and measurements were
performed on the right arm at heart level while children sat
comfortably. Systolic blood pressure (SBP) and diastolic
blood pressure (DBP) were measured on the right arm after
a 10min rest. Three measurements were taken for each
child and the average of the three was calculated. Hyper-
tension was defined as average SBP and/or DBP $95th
percentile for age, sex and height(8).
Biochemical analysis of plasma
In a fasting state, total cholesterol, HDL-cholesterol (HDL-C),
LDL-cholesterol (LDL-C), TAG, glucose and uric acid were
measured applying enzymatic assays using an automated
analyser (Olympus AU5400; Olympus Diagnostics, Nyon,
Switzerland). Additionally, insulin was determined by electro-
chemiluminescence with a modular autoanalyser (Cobas
8000, e602 module; Roche Diagnostics, Basel, Switzerland).
The homeostasis model assessment–insulin resistance
(HOMA-IR) was calculated as the product of the fasting
plasma insulin level (mU/l) and the fasting plasma glucose
level (mmol/l), divided by 22?5.
High LDL-C was defined as $130mg/dl(9); low HDL-C
as #40mg/dl(10); high TAG as $110mg/dl(10); high glu-
cose as $110mg/dl(10); high insulin as .15 mU/l(11); and
high uric acid as $6?7mg/dl for boys and $6?0mg/dl for
girls(12). Because HOMA-IR cut-off points for diagnosis of
insulin resistance have not been defined for children and
adolescents, values$3?6 ($11?65 SD or 95th percentile of
our control group(13)) were considered as high. Hyper-
tension, low HDL-C, high TAG, high glucose and high
insulin were included in analysing the clustering of
metabolic risk factors(14).
Statistical methods
Univariate descriptive statistics were presented as means
and standard deviations. The use of Quantile–Quantile
plots and Kolmogorov–Smirnov goodness-of-fit tests indi-
cated no significant evidence for deviation from normal
distribution for all variables; thus the medians were not
reported and all tests carried out were parametric.
To examine associations of metabolic and vascular
comorbidities with childhood overweight and obesity,
comorbidity variables were compared between the three
groups (normal weight, overweight and obesity). Since BMI
groups are ordinal variables, the one-way ANOVA proce-
dure with a test of linearity was used for testing the
hypothesis that the three means were equal. When there
was evidence of differences in means between groups, post
hoc multiple comparisons were performed using the Tukey
test for the three pairwise comparisons to determine which
means differed. To account for a potential confounding role
of sex and age in these associations, multivariate analysis,
namely general linear model (GLM), was used for the
adjustment with each comorbidity variable as the depen-
dent variable and the BMI group as the independent factor
controlling simultaneously for age and sex. Only the main
effects were evaluated because there were no significant
interaction terms. Hosmer–Lemeshow goodness-of-fit tests
were used to assess the adequacy of each of these models,
i.e. whether they adequately accounted for the relationship
between the response variable (each comorbidity variable)
and the predictors.
To determine whether high values for comorbidities
(or low values for HDL-C) were associated with BMI groups,
crude odds ratios (cOR) were calculated for each comor-
bidity variable. A Mantel–Haenszel x2 test for trend was
used to determine whether there were trends in proportions
when moving from normal weight, to overweight, to obese.
Multivariate binary logistic regression was used to compute
the adjusted odds ratios (aOR) and their 95% confidence
intervals, controlling for sex and age.
The statistical software packages SPSS version 19?0 and
R version 2?10?1 were used for the analyses. P values#
0?05 were considered statistically significant.
Results
Table 1 presents the sample’s clinical and biological char-
acteristics. Of the 149 (ninety-nine boys and fifty girls)
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school-aged children and adolescents, fifty-five (37%) were
classified as having normal weight, thirty-three (22%) as
overweight and sixty-one (41%) as obese. Age ranged from
8 to 18 years, with no significant mean differences between
BMI groups. There were statistically significant linear mean
differences between BMI groups in weight, height-for-age
Z-score, SBP, HDL-C, TAG, insulin, HOMA-IR and uric
acid. With the exception of HDL-C (which, as expected,
showed a decreasing trend), LDL-C (non-significant increa-
sing trend) and glucose, there were statistically significant
increasing trends for the mean differences of all the
biochemical variables across BMI groups, i.e. overweight
children had higher values compared with the normal-
weight group, and similarly obese children had higher
values compared with overweight children (except HDL-C
with the reverse). The significant differences in means were
all driven by the mean difference between normal weight
and obesity and, for some variables (HDL-C, insulin and
HOMA-IR), the mean difference between overweight
and obesity. Only for HDL-C was the overall difference
explained by the difference in mean between normal
weight and overweight. After controlling simultaneously for
sex and age, the above significant differences in means
remained significant.
Table 2 presents prevalence and crude and adjusted
odds ratios for the CVD risk factors. The prevalence of high
SBP, high BP, high LDL-C, low HDL-C, high TAG, high
insulin and high HOMA-IR increased significantly when
moving from the normal-weight group to overweight and
to obese, as evidenced by the trend P value. There was a
non-significant increase in the prevalence of high uric acid.
Only two children had high plasma glucose levels and
both were obese. Likewise, only one obese child had
high DBP.
Compared with normal-weight children (the reference
group), the odds ratios for all of the CVD risk factors
were greater than one (Table 2). The probability of
having risk factors increased in overweight children
compared with the normal-weight group, and in obese
children compared with the overweight group. Obese
children were significantly 10?6 times more likely than
normal-weight children to have hypertension. cOR for
other associations were 60?2 (high insulin), 39?5 (high
HOMA-IR), 27?9 (high TAG), 16?0 (low HDL-C), 4?3 (high
LDL-C) and 3?6 (high uric acid). Overweight children
were 3?5 times more likely than normal-weight children
to have hypertension, high insulin (cOR5 28?2), high
HOMA-IR (cOR5 23?3) and high TAG (cOR5 16?1), with
cOR significantly greater than one compared with the
reference group. Except for HOMA-IR, uric acid and
insulin, the cOR and aOR were very similar.
The clustering of cardiometabolic risk factors (hyper-
tension, low HDL-C, high TAG, high glucose and high
insulin) is presented in Table 3. A total of 101 children
had results for all variables required for this analysis. The
great majority (94%) of children in the normal-weight
group had no risk factors, while only 43% and 8% of
the overweight and obese children, respectively, were
free from any risk factor. Overall, nearly 92% of the obese
children had one or more CVD risk factors, compared
with 57% of the overweight children and 6% of the
normal-weight children. None of the children had more
than three risk factors. There was a significant positive
trend association between the number of risk factors and
Table 1 Clinical and biological characteristics (mean and SD) of the sample of 8–18-year-olds according to BMI group using the
WHO cut-offs
Overall sample Normal weight Overweight Obesity
(n 149) (n 55; 36?9 %) (n 33; 22?2 %) (n 61; 40?9 %)
Mean SD Mean SD Mean SD Mean SD
Age (years) 14?6 2?8 15?1 2?9 14?9 2?6 14?2 2?8
Boys/girls (n) 99/50 34/21 23/10 42/19
Weight (kg) 57?5yyy,JJJ 19?6 45?1 12?7 58?0*** 15?2 68?3---,--- - 20?5
Height (cm) 155?2 14?8 155?6 15?8 156?0 12?3 154?4 15?3
BMI-for-age (Z-score) 1?50yyy,JJJ 1?30 0?04 0?60 1?66*** 0?29 2?73---,- -- --- 0?55
Height-for-age (Z-score) 0?68y,J 1?00 0?47 1?01 0?67 1?06 0?88- 0?94
SBP (mmHg) 110?0yyy,JJJ 12?3 104?9 11?9 110?6 11?2 114?3--- 11?7
DBP (mmHg) 61?4 8?0 59?4 7?7 62?8 7?5 62?4 8?5
LDL-C (mg/dl) 95?7 24?9 91?0 23?3 97?7 24?6 99?0 26?3
HDL-C (mg/dl) 53?1yyy,JJJ 1?0 59?2 10?9 53?6* 10?1 47?0---,--- - 7?8
TAG (mg/dl) 85?4yyy,JJJ 44?7 65?5 18?3 86?5 31?9 103?4--- 58?5
Glucose (mg/dl) 90?0 7?0 88?7 5?9 91?4 6?0 90?4 8?1
Insulin (mU/l) 15?6yyy,JJJ 10?3 9?1 3?4 13?5 5?8 20?6---,--- - 12?1
HOMA-IR 3?5yyy,JJJ 2?4 2?0 0?8 3?0 1?3 4?6---,--- - 2?8
Uric acid (mg/dl) 4?7y,JJ 1?3 4?3 1?2 4?6 1?3 5?0- 1?4
SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL-C, LDL-cholesterol; HDL-C, HDL-cholesterol; HOMA-IR, homeostasis model assessment–
insulin resistance.
Mean values were significantly different, normal weight v. overweight: *P, 0?05, **P, 0?01, ***P, 0?001.
Mean values were significantly different, normal weight v. obesity: -P, 0?05, --P, 0?01, ---P, 0?001.
Mean values were significantly different, overweight v. obesity: -
-
P, 0?05, -
-
-
-
P, 0?01, -
-
-
-
-
-
P, 0?001.
Overall equality of means: yP, 0?05, yyP, 0?01, yyyP, 0?001.
Linearity for overall equality of means: JP, 0?05, JJP, 0?01, JJJP, 0?001.
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BMI group (P, 0?001), i.e. when moving from normal
weight to overweight to obese, the number of risk factors
increased.
Discussion
The results of our study indicate that obese and over-
weight school-aged children and adolescents as defined
by the WHO reference BMI-for-age cut-offs are at sub-
stantially increased risk for adverse levels of several CVD
risk factors. Obese children were several times more
likely than normal-weight children to have hypertension,
high insulin, high HOMA-IR, high TAG, low HDL-C,
high LDL-C and high uric acid. Similarly, children in
the overweight category were at higher risk of having
hypertension, high insulin, high HOMA-IR and high TAG,
compared with normal-weight children. The WHO BMI
cut-offs at 19 years closely coincide with the definitions
for adult overweight (BMI5 25?0 kg/m2) at 11 SD and
adult obesity (BMI5 30?0 kg/m2) at 12 SD, which were
derived on the basis of associations with mortality(15). As
there were no similar associations with functional out-
comes in the school age and adolescence periods, the
BMI cut-offs at 19 years where tracked back along the
11 SD and 12 SD lines to age 5 years(4). These results
provide evidence that the WHO cut-offs for childhood
overweight and obesity are well suited to identifying
children with metabolic and vascular risk.
Results presented in the current paper apply to children
aged 8–18 years. In younger children, it is entirely possible
that a given percentile represents varying levels of risk
given the rapid growth and physiological changes that
characterize early childhood. In effect, the terminology
used by WHO for overweight and obesity in younger
children (0–5 years) is different from that used for school-
aged children and adolescents. In children of pre-school
age, those above 11 SD are described as being ‘at risk
of overweight’, above 12 SD as overweight and above
13 SD as obese(5,16). WHO opted for a cautious approach
because young children are still growing and so far there
are few data on the functional significance of the cut-offs
for the upper end of the BMI-for-age distribution at such
young ages(17). Caution is all the more important given the
risk for very young children, in light of their nutrient
requirements for growth and development, of being
placed on restrictive diets. Until more evidence becomes
available, clinicians might prefer to avoid classifying a child
in this age range (0–5 years) and focus instead on the
individual growth trajectory and the clinical assessment.
Clinicians can also use more proximate measures of body
fat such as the triceps and subscapular skinfolds for which
standards are now available(18).
The strong association – as depicted by the high OR –
between obesity and overweight and adverse levels of
SBP, HOMA-IR, fasting insulin, TAG and HDL-C is striking.T
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Compelling evidence exists that the atherosclerotic
process begins in childhood and progresses slowly into
adulthood, at which time it leads frequently to CHD,
a major cause of death worldwide(9). Compared with
normal-weight controls, obese children and adolescents
have shown a significant increase in several indices of
arterial wall stiffness in the common carotid artery, indi-
cating the beginning of vascular dysfunction. Moreover,
the same study revealed that BMI, SBP and TAG were
positively correlated with these arterial parameters(19).
Obese and overweight children are also at increased risk
of developing non-alcoholic fatty liver disease which is
associated with progressive liver disease, cirrhosis and
the need for transplantation, and may also contribute to
CVD through the release of pro-inflammatory mediators
that damage the endothelium(20). This is yet another
urgent reason to address the global time bomb of child-
hood obesity.
Relatively little is known about the clustering of CVD risk
factors among children and adolescents, largely due to the
disparity between different cut-offs used to define adverse
levels(14). Previous analyses such as those from the Boga-
lusa Heart Study(21) and other populations(22) found that
clustering of CVD risk factors was highly prevalent in obese
children. In our study, as many as 40% of obese children
had two or three risk factors. As the number of CVD risk
factors increases, so does the severity of asymptomatic
coronary and aortic atherosclerosis in children and young
adults(23). Therefore, the use of the WHO cut-offs for
childhood obesity as a screening tool for risk factor clust-
ering may be particularly useful in the early identification of
children likely to develop CVD.
Understanding how different cut-offs (e.g. WHO, Inter-
national Obesity Taskforce (IOTF) or others) affect identi-
fication of adverse cardiometabolic risk profiles is essential
for appropriately identifying children with cardiometabolic
abnormalities. Recent research supports our results and
demonstrates that the WHO-defined classification of over-
weight is associated with a range of cardiometabolic risk
factors in adolescents, including carotid artery stiffness as
an early marker of vascular lesions(19,24). The skewness of
the IOTF and WHO set of centiles is very similar, but
the IOTF overweight cut-offs are higher than those of the
WHO because their equivalent standard deviation scores
are 1?24 (girls) and 1?31 (boys)(25) as against the WHO’s
standard deviation score of 1?0 for boys and girls(4). This
results in the IOTF cut-offs missing a large number of
children and adolescents who present unfavourable levels
of fasting lipids, glucose and insulin, and SBP and DBP.
Other reasons for concern with the newly proposed
IOTF cut-offs include the improbability that over 15% of a
sample of Chinese children aged 2–5 years would be
morbidly obese(25).
Our study has some limitations. The population is drawn
from paediatric care centres, the age range is wide (high
BMI at 8 years may not have the same metabolic impact as
at 18 years) and results are not necessarily applicable
elsewhere (Latin population). Notwithstanding these con-
straints, a recent Canadian study based on a large popula-
tion-representative sample of North American children
aged 9–16 years(24) reported similar associations to those
presented herein. Kakinami et al.’s study and ours, based
on different populations and study designs, should reassure
users of the WHO cut-offs that children and adolescents
classified as overweight and/or obese on this basis indeed
have higher metabolic and vascular risks.
Another weakness of the present study concerns
the criteria for defining high levels of the biochemical
variables (i.e. total cholesterol, HDL-cholesterol, LDL-
cholesterol, TAG, glucose, insulin and uric acid) for the
age groups concerned. The cut-offs for these variables in
current use are largely adapted from adult definitions
and do not necessarily apply to children(14). We used the
cut-offs more widely accepted; however, because of the
age- and sex-dependent changes during childhood and
adolescence, there is a need to develop unified child-
hood-specific criteria for defining high levels of lipids,
glucose, insulin, HOMA-IR and uric acid, as well as
to reach consensus on the definition of ‘metabolic
syndrome’ in children and adolescents. Unified classifica-
tion criteria will help achieve comparable study results
and avoid the likelihood of different diagnoses.
Conclusions
Obesity and overweight in school-aged children and
adolescents, defined using the WHO BMI-for-age cut-offs,
identify children with higher metabolic and vascular risk.
Table 3 Clustering of metabolic risk factors among the sample of 8–18-year-olds according to BMI group using the WHO cut-offs
Overall sample Normal weight Overweight Obese
Number of risk factorsz % n % n % n % n
0 42?6 43 93?8 30 42?9 9 8?3 4
1 35?6 36 6?2 2 42?9 9 52?1 25
2 14?9 15 0?0 0 4?8 1 29?2 14
3zz 6?9 7 0?0 0 9?5 2 10?4 5
Total 100?0 101 100?0 32 100?0 21 100?0 48
zHypertension, low HDL-cholesterol, high TAG, high glucose and high insulin.
zzNone of the children had more than three risk factors.
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These cut-offs are clinically meaningful and thus valuable
in identifying individual children and populations in need
of CVD-prevention strategies. Our findings emphasize the
importance of prevention of overweight and obesity in
children and adolescents to reduce cardiovascular risk.
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